Method of using modified oligonucleotides for hepatic delivery
Details for Australian Patent Application No. 2003213150 (hide)
Event Publications
24 July 2003 Complete Application Filed
Priority application(s): 10/080,979 22.02.02 US
16 October 2003 Application Open to Public Inspection
Published as AU-A-2003213150
23 October 2003 Application Open to Public Inspection
Published as AU-A-2003213150
23 September 2004 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 25 Aug 2004
8 March 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003213151-CONTROLLED RELEASE SOLID DOSAGE CARBAMAZEPINE FORMULATIONS
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser